Elsevier Publishes Five New Cancer Therapy Books

New books featured at AACR Annual Meeting April 5-9 reflect trend toward personalized cancer treatment

Waltham, MA, April 7, 2014

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of five new cancer therapy books, including Cancer Theranostics, edited by Xiaoyuan Chen and Stephen Wong. All of the new books will be featured at this week’s American Association for Cancer Research (AACR) Annual Meeting April 5-9 in San Diego at Elsevier’s booth #635.

As part of the trend toward personalized treatment of cancer, cancer theranostics is an approach for diagnosing and treating cancer that aims to eliminate multi-step procedures, reduce delay in treatment and ease patient care, all of which are important factors for personalized cancer treatment. The new book, Cancer Theranostics, reviews, assesses and makes pertinent clinical recommendations on the integration of comprehensive in vitro diagnostics, in vivo molecular imaging and individualized treatments towards the personalization of cancer treatment. It also describes the identification of novel biomarkers to advance molecular diagnostics of cancer and discusses nanotechnology platforms incorporating cancer imaging, therapeutic components, clinical translation and future perspectives.

Dr. Chen, the principal editor of Cancer Theranostics, is an expert in the fast-developing field of theranostics and cancer prognosis. He is Senior Investigator and Lab Chief at the National Institute of Biomedical Imaging and Bioengineering, part of the National Institutes of Health. Dr. Chen is also Editor-in-Chief of Theranostics, on the board for several other journals, an editor of three books, and author of more than 150 papers. Dr. Wong is John S. Dunn Distinguished Endowed Chair of Biomedical Engineering at Houston Methodist Hospital, the Founding Chair of Department of Systems Medicine and Bioengineering at Houston Methodist Research Institute, and a Professor of Radiology, Neurosciences, Pathology, and Laboratory Medicine at Weill Cornell Medical College.

The five new cancer therapy books published are:

The books are available on the Elsevier Store and on ScienceDirect, Elsevier’s full-text scientific database offering journal articles and book chapters from more than nearly 2,200 peer-reviewed journals, almost 900 serials and 25,000 book titles.

---

Notes for Editors
Review copies of the books are available to credentialed journalists upon request. Contact Michelle McMahon at m.mcmahon.1@elsevier.com or +1 781 663 2268.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Michelle McMahon
Publicity Manager, Science & Technology Books
Elsevier
+1 781 663 2268
m.mcmahon.1@elsevier.com